Latest news with #BectonDickinson
Zawya
15 hours ago
- Business
- Zawya
Charting a value-driven healthcare future: BD Saudi Arabia's GM on local impact, innovation, and Vision 2030
In a candid conversation with Saudi Gazette, Omar Malabarey, newly appointed Country General Manager for Becton Dickinson in Saudi Arabia, shares his vision for the company's role in the Kingdom's fast-evolving healthcare sector. With decades of experience across public and private healthcare, Malabarey discusses BD's commitment to local talent development, digital transformation, and strategic partnerships aligned with Vision 2030. Q: Congratulations on your appointment as General Manager of BD in Saudi Arabia. Can you share your journey leading to this role and what it means to you? A: My journey in healthcare has been both dynamic and fulfilling. I graduated in Radiological Sciences from the University of Wales (UK)and began my career as a radiology technologist at a Military hospital in Riyadh, Saudi Arabia. Following a decade in public healthcare, I transitioned to the corporate sector, where I held several senior leadership roles in digital health services. My journey then took me to the Ministry of Investment (formerly SAGIA), where I was the managing director for healthcare investment and promotion efforts responsible of medical devices , medical services , digital health and pharmaceutical investments . Before joining BD, I held the role of Chief commercial officer (CCO)at the National Unified Procurement Company) NUPCO. Stepping into this role at BD is a natural continuation of my mission to enhance the healthcare ecosystem system in KSA. BD has a legacy of innovation in medical technology, and I am honoured to lead its efforts in Saudi Arabia to drive impactful healthcare transformation. Q: What are your immediate priorities as you take on this role? A: My priorities span both internal and external objectives. Internally, I am focused on fostering a strong, collaborative workplace culture. A key priority is to establish BD as an employer of choice in Saudi Arabia, attracting and retaining top local talent while ensuring alignment with the Kingdom's Saudization initiatives. Externally, my goal is to strengthen BD's presence and visibility in the Saudi market. While BD products are widely recognized, our corporate brand needs greater prominence among healthcare stakeholders. I want to position BD as not just a provider of high-quality medical technology but also as a key partner in Saudi Arabia's Vision 2030 and the Health Sector Transformation Program. Our focus is on value-driven healthcare—delivering not just products but comprehensive solutions, education, and best practices that enhance patient outcomes. A strong part of my role will be pursue rolling out our Signature Programmes™ in Saudi Arabia, which focus on three critical areas: Patient Safety, Healthcare Worker Safety, and Healthcare Efficiency. These initiatives are designed to enhance infection control, improve hospital workflows, and to help ensure the safety of both patients and medical professionals. Through these programmes, BD is helping hospitals and healthcare institutions in Saudi Arabia implement best practices that drive meaningful improvements in patient outcomes and operational efficiencies. Q: Why is Saudi Arabia a strategic market for BD, and how does the company align with Vision 2030? A: Saudi Arabia is undergoing a rapid and ambitious healthcare transformation under the leadership of the custodian of the two holy mosques King Salman and HRH the Crown Prince Mohammed bin Salman. Vision 2030's Health Sector Transformation Program aims to create a world-class healthcare system that is efficient, patient-centric, and digitally advanced. BD is fully aligned with this vision. We are not just a medical technology provider but a healthcare solutions partner, committed to driving innovation, education, and collaboration. Our focus is on automation, digital health solutions, and value-based procurement, all of which contribute to making healthcare more efficient and accessible. Saudi Arabia's commitment to digitalization is unmatched. It is the leading nation in digitization, and we see this reflected in healthcare. BD is supporting this shift by introducing smart medication management systems and robotics to enhance pharmacy automation, reduce human error, and improve patient care. Q: BD has several initiatives in Saudi Arabia. Can you highlight some of the key programs and investments? A: Certainly. BD has evolved from a scientific office to a full commercial entity in Saudi Arabia, employing approximately 170 professionals and working alongside seven strategic distributors. Our commitment to Saudization is strong, and we continue to develop local talent in line with national workforce initiatives. One of our most exciting developments is the BD Training Center in Riyadh, which officially launched in April this year. This state-of-the-art facility will serve as a hub for healthcare professionals, providing hands-on training on BD's medical technologies, best practices, and clinical applications. It will also support technical training for engineers, ensuring seamless device maintenance and optimization. Recently, we also hosted our inaugural BD Healthcare Summit in Riyadh under the theme 'Embracing a Value Driven Future,' bringing together healthcare leaders to explore how AI, automation, and workforce empowerment can drive better outcomes in line with Saudi Arabia's Vision 2030. Additionally, BD has established a Regional Headquarters (RHQ) in Saudi Arabia, reinforcing our commitment to regional operations and market expansion. On the collaboration front, we have signed an MoU with STC to explore digital health solutions and are in discussions with multiplekey players to drive healthcare innovation. We also have an ongoing partnership with the Saudi Nursing Association, focusing on enhancing nursing education and clinical competency. Q: What are some of the new technologies BD is bringing to Saudi Arabia? A: Saudi Arabia is embracing cutting-edge healthcare solutions, and BD is at the forefront of this transformation. One of our key areas of focus is medication management systems and robotics, which optimize pharmacy automation, helping to ensure precise and efficient medication dispensing. These technologies not only enhance patient safety but also improve workflow efficiency in hospitals and pharmacies. We are also expanding our digital health solutions, aligning with Saudi Arabia's drive for smart healthcare systems. Our goal is to integrate automation, data-driven healthcare, and AI-supported medical technologies that elevate patient care standards. Q: Are there any partnerships or collaborations BD is working on in Saudi Arabia? A: Yes, partnerships are a key pillar of BD's strategy in Saudi Arabia. We have collaborated with Al Mujtamaa Pharmacy, making it the first digitally enabled pharmacy in Saudi Arabia using BD's advanced technology solutions. Additionally, BD has signed an MoU with STC, with further partnerships in discussion with Mobily and others toadvance digital healthcare and supply chain efficiency. A notable collaboration is our partnership with the Saudi Nursing Association, which focuses on continuous education and professional development for nurses across the Kingdom. This initiative underscores BD's commitment to capacity-building in the healthcare workforce. Q: What key trends do you see shaping the future of the Saudi healthcare sector, and how is BD contributing? A: The Saudi healthcare sector is moving toward value-based healthcare and value-based procurement models, where hospitals and institutions prioritize quality outcomes over mere cost efficiency. BD is actively engaging in this transition, particularly in laboratory solutions and diagnostics. Another major trend is digital transformation, where automation and data analytics are playing a pivotal role in improving healthcare services. BD is driving innovation in pharmacy automation, digital medication management, and clinical diagnostics to support this shift. Additionally, we see a strong push toward local manufacturing and public-private partnerships, and BD is keen to explore opportunities that align with these national priorities. Q: As a leader, what is your vision for BD's role in Saudi Arabia? A: My vision is clear: BD is here to stay and to lead. We are not just another healthcare technology provider; we are a long-term partner in Saudi Arabia's healthcare journey. Our role extends beyond revenue growth—we are committed to delivering value to patients, healthcare professionals, and the government. BD will continue to support innovation, drive medical education, and contribute to the national healthcare transformation through strategic partnerships and advanced solutions. A major part of this commitment is our focus on our Signature Programmes™, which align with the Kingdom's healthcare objectives. Through our investments, workforce development, and collaborations, BD is reinforcing its position as a trusted healthcare enabler in the Kingdom. Q: Any final thoughts or messages you'd like to share? A: I want to emphasize that BD's mission in Saudi Arabia is deeply rooted in improving patient care and healthcare efficiency. We are here not just to provide medical devices but to transform the healthcare experience, ensuring better outcomes for patients and healthcare professionals alike. Innovation is at the heart of BD, and we will continue to introduce cutting-edge technologies and best practices that align with the Kingdom's Vision 2030. Our training center, our partnerships, and our digital health initiatives all reflect BD's dedication to making a meaningful impact in Saudi Arabia's healthcare landscape. © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Saudi Gazette
2 days ago
- Business
- Saudi Gazette
Charting a value-driven healthcare future: BD Saudi Arabia's GM on local impact, innovation, and Vision 2030
In a candid conversation with Saudi Gazette, Omar Malabarey, newly appointed Country General Manager for Becton Dickinson in Saudi Arabia, shares his vision for the company's role in the Kingdom's fast-evolving healthcare sector. With decades of experience across public and private healthcare, Malabarey discusses BD's commitment to local talent development, digital transformation, and strategic partnerships aligned with Vision 2030. Q: Congratulations on your appointment as General Manager of BD in Saudi Arabia. Can you share your journey leading to this role and what it means to you? A: My journey in healthcare has been both dynamic and fulfilling. I graduated in Radiological Sciences from the University of Wales (UK)and began my career as a radiology technologist at a Military hospital in Riyadh, Saudi Arabia. Following a decade in public healthcare, I transitioned to the corporate sector, where I held several senior leadership roles in digital health services. My journey then took me to the Ministry of Investment (formerly SAGIA), where I was the managing director for healthcare investment and promotion efforts responsible of medical devices , medical services , digital health and pharmaceutical investments . Before joining BD, I held the role of Chief commercial officer (CCO)at the National Unified Procurement Company) NUPCO. Stepping into this role at BD is a natural continuation of my mission to enhance the healthcare ecosystem system in KSA. BD has a legacy of innovation in medical technology, and I am honoured to lead its efforts in Saudi Arabia to drive impactful healthcare transformation. A: My priorities span both internal and external objectives. Internally, I am focused on fostering a strong, collaborative workplace culture. A key priority is to establish BD as an employer of choice in Saudi Arabia, attracting and retaining top local talent while ensuring alignment with the Kingdom's Saudization my goal is to strengthen BD's presence and visibility in the Saudi market. While BD products are widely recognized, our corporate brand needs greater prominence among healthcare stakeholders. I want to position BD as not just a provider of high-quality medical technology but also as a key partner in Saudi Arabia's Vision 2030 and the Health Sector Transformation Program. Our focus is on value-driven healthcare—delivering not just products but comprehensive solutions, education, and best practices that enhance patient outcomes.A strong part of my role will be pursue rolling out our Signature Programmes™ in Saudi Arabia, which focus on three critical areas: Patient Safety, Healthcare Worker Safety, and Healthcare Efficiency. These initiatives are designed to enhance infection control, improve hospital workflows, and to help ensure the safety of both patients and medical professionals. Through these programmes, BD is helping hospitals and healthcare institutions in Saudi Arabia implement best practices that drive meaningful improvements in patient outcomes and operational efficiencies.A: Saudi Arabia is undergoing a rapid and ambitious healthcare transformation under the leadership of the custodian of the two holy mosques King Salman and HRH the Crown Prince Mohammed bin Salman. Vision 2030's Health Sector Transformation Program aims to create a world-class healthcare system that is efficient, patient-centric, and digitally is fully aligned with this vision. We are not just a medical technology provider but a healthcare solutions partner, committed to driving innovation, education, and collaboration. Our focus is on automation, digital health solutions, and value-based procurement, all of which contribute to making healthcare more efficient and Arabia's commitment to digitalization is unmatched. It is the leading nation in digitization, and we see this reflected in healthcare. BD is supporting this shift by introducing smart medication management systems and robotics to enhance pharmacy automation, reduce human error, and improve patient care.A: Certainly. BD has evolved from a scientific office to a full commercial entity in Saudi Arabia, employing approximately 170 professionals and working alongside seven strategic distributors. Our commitment to Saudization is strong, and we continue to develop local talent in line with national workforce of our most exciting developments is the BD Training Center in Riyadh, which officially launched in April this year. This state-of-the-art facility will serve as a hub for healthcare professionals, providing hands-on training on BD's medical technologies, best practices, and clinical applications. It will also support technical training for engineers, ensuring seamless device maintenance and we also hosted our inaugural BD Healthcare Summit in Riyadh under the theme 'Embracing a Value Driven Future,' bringing together healthcare leaders to explore how AI, automation, and workforce empowerment can drive better outcomes in line with Saudi Arabia's Vision BD has established a Regional Headquarters (RHQ) in Saudi Arabia, reinforcing our commitment to regional operations and market the collaboration front, we have signed an MoU with STC to explore digital health solutions and are in discussions with multiplekey players to drive healthcare innovation. We also have an ongoing partnership with the Saudi Nursing Association, focusing on enhancing nursing education and clinical competency.A: Saudi Arabia is embracing cutting-edge healthcare solutions, and BD is at the forefront of this transformation. One of our key areas of focus is medication management systems and robotics, which optimize pharmacy automation, helping to ensure precise and efficient medication dispensing. These technologies not only enhance patient safety but also improve workflow efficiency in hospitals and are also expanding our digital health solutions, aligning with Saudi Arabia's drive for smart healthcare systems. Our goal is to integrate automation, data-driven healthcare, and AI-supported medical technologies that elevate patient care standards.A: Yes, partnerships are a key pillar of BD's strategy in Saudi Arabia. We have collaborated with Al Mujtamaa Pharmacy, making it the first digitally enabled pharmacy in Saudi Arabia using BD's advanced technology solutions. Additionally, BD has signed an MoU with STC, with further partnerships in discussion with Mobily and others toadvance digital healthcare and supply chain efficiency.A notable collaboration is our partnership with the Saudi Nursing Association, which focuses on continuous education and professional development for nurses across the Kingdom. This initiative underscores BD's commitment to capacity-building in the healthcare workforce.A: The Saudi healthcare sector is moving toward value-based healthcare and value-based procurement models, where hospitals and institutions prioritize quality outcomes over mere cost efficiency. BD is actively engaging in this transition, particularly in laboratory solutions and major trend is digital transformation, where automation and data analytics are playing a pivotal role in improving healthcare services. BD is driving innovation in pharmacy automation, digital medication management, and clinical diagnostics to support this we see a strong push toward local manufacturing and public-private partnerships, and BD is keen to explore opportunities that align with these national priorities.A: My vision is clear: BD is here to stay and to lead. We are not just another healthcare technology provider; we are a long-term partner in Saudi Arabia's healthcare role extends beyond revenue growth—we are committed to delivering value to patients, healthcare professionals, and the government. BD will continue to support innovation, drive medical education, and contribute to the national healthcare transformation through strategic partnerships and advanced solutions.A major part of this commitment is our focus on our Signature Programmes™, which align with the Kingdom's healthcare objectives. Through our investments, workforce development, and collaborations, BD is reinforcing its position as a trusted healthcare enabler in the Kingdom.A: I want to emphasize that BD's mission in Saudi Arabia is deeply rooted in improving patient care and healthcare efficiency. We are here not just to provide medical devices but to transform the healthcare experience, ensuring better outcomes for patients and healthcare professionals is at the heart of BD, and we will continue to introduce cutting-edge technologies and best practices that align with the Kingdom's Vision 2030. Our training center, our partnerships, and our digital health initiatives all reflect BD's dedication to making a meaningful impact in Saudi Arabia's healthcare landscape.
Saudi Gazette
2 days ago
- Business
- Saudi Gazette
BD Saudi Arabia charts a value-driven healthcare future under new leadership
Becton Dickinson (BD) in Saudi Arabia today announced its reinforced commitment to the Kingdom's ambitious healthcare transformation under the leadership of its newly appointed Country General Manager, Omar Malabarey. With a distinguished career spanning public and private healthcare sectors, Malabarey brings a wealth of experience and a clear vision to drive BD's impact on the local healthcare ecosystem. Malabarey's appointment marks a pivotal moment for BD Saudi Arabia, as he aims to leverage BD's global legacy of innovation in medical technology to foster value-based healthcare solutions, cultivate strategic partnerships, and champion local talent development, all in strong alignment with Saudi Arabia's Vision 2030. "Joining BD is a natural continuation of my mission to elevate the healthcare ecosystem in the Kingdom," said Omar Malabarey. "My focus is on creating a long-lasting impact by delivering solutions that not only enhance patient care and safety but also contribute to the efficiency and modernization of the entire healthcare system." Internally, Malabarey is dedicated to cultivating a collaborative and empowering workplace culture, positioning BD as an employer of choice for Saudi talent. Externally, his priority is to elevate BD's corporate identity beyond its well-recognized products, establishing the company as a trusted partner in healthcare transformation. Central to BD's strategic approach are its Signature Programmes™️, which address three critical areas: Patient Safety, Healthcare Worker Safety, and Healthcare Efficiency. These initiatives are designed to empower hospitals across Saudi Arabia to implement best practices in infection control, optimize workflows, and ultimately improve outcomes for both patients and medical professionals. Highlighting Saudi Arabia as a strategic and pioneering market in digital healthcare, Malabarey emphasized the Kingdom's rapid progress towards a modern, efficient, and patient-centered healthcare model under Vision 2030 and the Health Sector Transformation Program. BD is actively contributing to this shift with smart medication management systems, pharmacy robotics, and digital health solutions designed to minimize human error and maximize care has significantly expanded its local presence, now employing approximately 170 professionals and operating through seven strategic distributors. Reinforcing its commitment to local development, BD recently launched the state-of-the-art BD Training Center in Riyadh in April, providing hands-on clinical and technical training for healthcare professionals and biomedical engineers. The company also hosted its inaugural BD Healthcare Summit, convening key stakeholders to discuss the future of AI, automation, and workforce development in collaborations underpin BD's commitment to the Kingdom. These include partnerships with STC and Mobily to explore digital health innovations, a pioneering collaboration with Al Mujtamaa Pharmacy, making it the first digitally enabled pharmacy in Saudi Arabia, and a partnership with the Saudi Nursing Association aimed at developing clinical competencies and supporting the healthcare ahead, Malabarey envisions BD as a long-term healthcare enabler in Saudi Arabia, deeply invested not just in growth but in meaningful impact. From supporting local workforce initiatives to driving best practices in clinical care, BD is poised to be a central player in the country's ongoing healthcare transformation.
Yahoo
3 days ago
- Business
- Yahoo
Enteral Feeding Devices Market - Global Forecast to 2030: High Growth Opportunities in Emerging Economies and Growing Demand for Enteral Feeding in Home Care Settings
The global enteral feeding devices market is set to grow from USD 2.96 billion in 2025 to USD 3.99 billion by 2030. This expansion is fueled by advancements in medical technology and rising demand due to chronic illnesses, geriatric population increase, and home healthcare needs. Enteral feeding tubes will dominate the segment, driven by the oncology sector's rapid adoption, especially in hospitals and surgical centers for enhanced patient outcomes. Asia Pacific is expected to witness significant growth owing to demographic changes and economic factors. Key players include Fresenius, Cardinal Health, and Becton Dickinson. The report provides detailed insights into market dynamics, opportunities, and competitive landscape analysis for informed investment and strategic decision-making. Enteral Feeding Devices Market Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Enteral Feeding Devices Market by Type (Feeding Tubes (NG, NJ, OG, Gastronomy), Pumps: Feeding, Syringes; Consumables), Age (Neonates, Pediatric, Adult), Application (Oncology, GIT, Neuro, Diabetes), End User (Hospitals, Home, ASC) - Global Forecast to 2030" report has been added to global market for enteral feeding devices is projected to reach USD 3.99 billion by 2030, from USD 2.96 billion in 2025 This expansion is largely driven by advancements in medical technology, which have made enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to market growth include competition within the industry, demographic shifts, economic factors, globalization, patient-centered design, digital integration, and sustainability considerations. The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international feeding tubes to be largest segment during forecast periodThe enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these to surpass other applications during forecast periodIn 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient's quality of life and outcomes pertaining to a cancer & surgical centers segment to be prevalent during forecast periodHospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers. Prominent players in this market are Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among Coverage Market Dynamics: Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enteral feeding devices market Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product & service launches in the enteral feeding devices market Market Development: Comprehensive information about lucrative markets Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the enteral feeding devices market Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others Key Attributes: Report Attribute Details No. of Pages 302 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $2.96 Billion Forecasted Market Value (USD) by 2030 $3.99 Billion Compound Annual Growth Rate 6.0% Regions Covered Global Premium Insights Attractive Opportunities for Players in Enteral Feeding Devices Market Enteral Feeding Devices Market, by Region Us Enteral Feeding Devices Market, by Country and End User Enteral Feeding Devices Market, by Country Market Dynamics Drivers Benefits and Cost-Effectiveness of Enteral Nutrition High Incidence of Preterm Births and Genetic Disorders in Pediatric and Neonatal Patients Rapid Growth in Geriatric Population and Age-Related Chronic Diseases Increasing Prevalence of Dysphagia Restraints Complications Associated With Enteral Feeding Devices Lack of Awareness About Feeding Tubes Opportunities High Growth Opportunities in Emerging Economies Growing Demand for Enteral Feeding in Home Care Settings Challenges Insufficient Reimbursement Policies in Emerging Economies Shortage of Endoscopy Specialists Porter's Five Forces Analysis Regulatory Landscape Regulatory Analysis Regulatory Bodies, Government Agencies, and Other Organizations Reimbursement Scenario Ecosystem Analysis Investment and Funding Scenario Technology Analysis Key Technologies Flow Generation Mechanisms Flow Control Technologies Complementary Technologies Smart Feeding Pumps Feeding Tube Replacement Technologies Adjacent Technologies Patient Monitoring Systems Digital Connectivity Nutrition Supplements Value Chain Analysis Research and Development Raw Material Procurement and Product Manufacturing Distribution, Marketing and Sales, and After-Sales Services Supply Chain Analysis Prominent Companies Small and Medium-Sized Enterprises End Users Companies Featured Fresenius SE & Co. KGaA Cardinal Health Nestle SA Avanos Medical, Inc. Danone SA Boston Scientific Corporation Becton, Dickinson and Company B. Braun Melsungen AG Conmed Corporation Cook Medical Moog, Inc. Baxter International Inc. Vygon Enteral Access Technologies Ltd. Fidmi Medical Lifepum Meditech Applied Medical Technology, Inc. Amsino International, Inc. Omex Medical Technology Danumed Medizintechnik GmbH. Medline Industries Fuji Systems Corporation Kentec Medical. Dynarex Corporation Vesco Medical, LLC Medela AG Alcor Scientific Romsons For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Enteral Feeding Devices Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
5 days ago
- Business
- Yahoo
Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Becton, Dickinson and Co. (NYSE:BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The 52-week range of Becton Dickinson stock price was $163.33 to $251.99. Becton Dickinson's dividend yield is 2.44%. It paid $4.16 per share in dividends during the last 12 months. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Invest Where It Hurts — And Help Millions Heal: On May 1, the company announced its Q2 2025 earnings, posting adjusted EPS of $3.35, beating the consensus estimate of $3.28, while revenues of $5.27 billion came in below the consensus of $5.35 billion, as reported by Benzinga. 'Amid a difficult operating environment impacting near-term organic revenue growth, our Q2 results reflect the strength of our business model and ability to exceed our earnings expectations through quality gross margin improvement,' said CEO Tom Polen. The company now expects full-year 2025 revenues to be between $21.8 billion and $21.9 billion, compared with its previously issued guidance of $21.7 billion to $21.9 billion. Check out this article by Benzinga for six analysts' insights on Becton Dickinson. Trending: If there was a new fund backed by Jeff Bezos offering a ? If you want to make $100 per month — $1,200 annually — from Becton Dickinson dividends, your investment value needs to be approximately $49,180, which is around 288 shares at $170.66 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (2.44% in this case). So, $1,200 / 0.0244 = $49,180 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling basis. For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). In summary, income-focused investors may find Becton Dickinson stock an attractive option for making a steady income of $100 per month by owning 288 shares of stock. There may be more upside to come as investors benefit from the company's consistent dividend hikes. Becton Dickinson has raised its dividend consecutively for the last 53 years. Real estate is a great way to diversify your portfolio and earn high returns, but it can also be a big hassle. Luckily, there are other ways to tap into the power of real estate without owning property. Arrived Home's Private Credit Fund's has historically paid an annualized dividend yield of 8.1%*, which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, Looking for fractional real estate investment opportunities? The features the latest offerings. Image: Shutterstock This article Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
